Based Quantification News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Apellis to Showcase Leadership in Retina at Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Nachrichtenquelle: globenewswire
 |  16.04.2021, 18:44  | 
82 
10 accepted abstracts include five oral presentations from pioneering artificial intelligence (AI) collaboration
Presentations support the potential of intravitreal pegcetacoplan, an investigational targeted C3 therapy, as the first treatment for geographic atrophy (GA)
WALTHAM, Mass., April 16, 2021 (GLOBE NEWSWIRE)
Apellis
Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 therapies, today announced that 10 abstracts were accepted for presentation at the
virtual Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting to be held May 1-7, 2021. These abstracts feature a breadth of data, from presentations that demonstrate ....

United States , Intravitreal Pegcetacoplan , Ursula Schmidt Erfurth , Mark Dole , Drug Administration , Exchange Commission , University Eye Hospital , Apellis Pharmaceuticals Inc , European Medicines Agency , Department Of Ophthalmology , Lancet Glob Health , University Of Vienna , Ophthalmic Image Analysis , Based Quantification , Photoreceptor Maintenance , Geographic Atrophy Secondary , Treatment Effects , Optical Coherence Tomography , Regional Progression , Deep Learning , Open Label , Single Arm Safety Study , Intravitreal Pegcetacoplan Supporting , Geographic Atrophy , Poster Abstract , Macular Degeneration ,